As shown in Fig. 4c, the mean TTI percentage values of the P407-DiR-SSD-Lps group exceeded those of the P407-DiR-Chol-Lps group at all observed time points, confirming superior tumor-targeting efficacy. The gene discussed is IRF6; the disease is neoplasm.